Heron Therapeutics' GAAP loss for 6M 2021 was $113.629 million, up 6.4% from $106.769 million in the prior year. Revenue declined 11.7% to $42.461 million from $48.068 million a year earlier.
Heron Therapeutics' GAAP loss for 6M 2021 was $113.629 million, up 6.4% from $106.769 million in the prior year. Revenue declined 11.7% to $42.461 million from $48.068 million a year earlier. 
ir.herontx.com
English (US) 